Bavarian Nordic will be supplying Public Health England with monkeypox vaccines, according to an announcement made by the vaccine and biotech company.
The British health authorities Public Health England (PHE) and the Medicines and Health Products Regulatory Agency (MHRA) have asked Bavarian Nordic to deliver the pox vaccine Imvanex to be used to combat new cases of monkeypox.
More from MedWatch
Experiences from Danish climate partnerships are among the tools that can be leveraged when Novo Nordisk CEO Lars Fruergaard begins stepping up efforts in the life science sector’s central organs in Brussels. ”I’ve been fired up by the intimacy and shared vision we could see in Denmark,” he tells MedWatch.